Colorectal Cancer Prevention Research Study: Eat Right, Screen Right

April 16, 2026 updated by: University of Florida

Eat Right, Screen Right: A Web-based, Self-paced Nutrition Risk Module and Cancer Prevention Resource

The Eat Right, Screen Right Extension program aims to help adult learners manage nutrition risks and screening options for colorectal cancer prevention. Participants navigate through 6 tailored lessons covering user-identified, evidence-based information relevant to reducing colorectal cancer risk. First, participants receive an overview of colorectal cancer screening guidelines (e.g., age, modalities), personalized nutrition risk factors (e.g., how their intake of red meat, processed meat, and alcohol aligns with nutrition guidelines for colorectal cancer prevention), and additional optional colorectal cancer prevention topics via a branched conversational pathway selected by the participant. Subsequently, participants also have the opportunity to access five additional modules, providing more in-depth information. Self-reported outcomes include changes in cancer information overload, dietary intentions, and cancer screening intentions. This is an extension of previously funded pilot study and aims to enhance reach by leveraging the UF/IFAS Extension infrastructure allowing participants to achieve the following goals: (1) demonstrate accurate understanding of the modifiable dietary behavior that decrease colorectal cancer risk, (2) demonstrate understanding of screening guidelines and several ways to screen for colorectal cancer (e.g., home stool tests, colonoscopy, others), (3) develop confidence to obtain colorectal cancer screening and stay up to date with screening based on guidelines, (4) apply behavior change strategies to support cancer prevention behaviors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Florida
      • Gainesville, Florida, United States, 32610
        • Recruiting
        • University Florida - Online Study
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Study Population

All populations welcome.

Description

Inclusion Criteria:

  • 18 years or older
  • Able to understand English
  • Access to a computer or mobile device

Exclusion Criteria:

  • 17 years or younger
  • Unable to understand English
  • No access to a computer or mobile device

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Single-Arm Participants
Other: Web-based module
Short, web-based modules via UF/IFAS's Extension's e-learning platform

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intentions to obtain colorectal cancer screening
Time Frame: From enrollment up to 24 months. If, within 8 weeks of enrollment, participants have not completed the self-paced intervention, a reminder to complete the intervention/post-evaluation will be sent via email.
Two self-report questionnaire measures on a 7-point Likert scale, where 1 = strongly disagree and 7 = strongly agree (i.e., I want to get screened for colorectal cancer, I plan to talk to my doctor about colorectal cancer)." On the 7-point Likert scale, higher scores would indicate stronger intentions to screen. We also ask one question about screening intentions/readiness with response options: a) I am not planning to screen in the next 6 months, b) I am thinking about screening, but not in the next 6 months, c) I am considering screening in the next 6 months, d) I am already taking steps to screen in the next 6 months.
From enrollment up to 24 months. If, within 8 weeks of enrollment, participants have not completed the self-paced intervention, a reminder to complete the intervention/post-evaluation will be sent via email.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Study Registration Dates

First Submitted

January 14, 2026

First Submitted That Met QC Criteria

January 30, 2026

First Posted (Actual)

February 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 16, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB202501397

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Cancer Prevention

Clinical Trials on Web-based module

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe